A phase 1 clinical trial at Mayo Clinic investigates allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) for lumbar facet joint arthropathy (LFJA).
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.